ArticleCureus2025
Pre- and Post-bronchodilator Spirometry in Asthmatic Smokers Versus Non-smokers: A Hospital-Based Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Cigarette smoking is a major risk factor for impaired lung function and the development of chronic respiratory diseases. Early detection of pulmonary changes using spirometry can help in timely intervention and prevention of long-term complications. Objective To compare spirometry parameters between smokers and non-smokers, and to evaluate the effect of bronchodilator administration on pulmonary function in both groups. Methods A cross-sectional study was conducted involving 60 participants (30 smokers and 30 non-smokers). Spirometry was performed before and after bronchodilator administration to measure vital capacity (VC%), forced vital capacity (FVC%), forced expiratory volume in the first second (FEV₁%), FEV₁/FVC ratio, forced expiratory flow over the middle one half of the FVC (FEF25-75%), maximal voluntary ventilation (MVV%), and expiratory time. Paired t-tests were used for within-group comparisons, and independent t-tests for between-group comparisons. A p-value < 0.05 was considered statistically significant. Results Smokers had significantly lower baseline spirometry values compared to non-smokers across all parameters (p < 0.001). Both groups showed statistically significant improvements post-bronchodilator (p < 0.001), with smokers exhibiting a smaller magnitude of improvement. Notably, FEV₁% increased from 47.2 ± 6.8 to 60.3 ± 11.5 in smokers and from 56.3 ± 7.1 to 73.3 ± 7.4 in non-smokers. The FEV₁/FVC ratio and other flow rates showed similar patterns. Expiratory time also increased post-bronchodilator in both groups. Conclusion Smoking is associated with marked reductions in lung function and diminished bronchodilator responsiveness. Early spirometric screening in smokers is essential to identify functional decline and guide smoking cessation and treatment strategies to prevent progression of pulmonary disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.